Status:
COMPLETED
Feasibility of Aromatherapy in an Awake Craniotomy Environment
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Intracranial Pathology
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a tradit...
Detailed Description
The lavender aromatherapy trial protocol was developed in conjunction with the Aurora Health Care (AHC) Integrative Medicine Department and Certified Clinical Aromatherapy Practitioners (CCAP). Partic...
Eligibility Criteria
Inclusion
- Any adult patient aged 18 and older undergoing awake cranial neurosurgery
Exclusion
- Allergy or sensitivity to the aromatherapy agent (Lavender)
- Aversion to lavender scent
- History of asthma, chronic obstructive pulmonary disease (COPD)
- History of contact dermatitis following exposure to cosmetic fragrances
- Pregnancy
Key Trial Info
Start Date :
April 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 12 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03328143
Start Date
April 3 2018
End Date
June 12 2019
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aurora Health Care, Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, United States, 53215